Circulating tumor DNA identified by targeted sequencing in advanced-stage non-small cell lung cancer patients-Reference-Cited by-同舟云学术

Circulating tumor DNA identified by targeted sequencing in advanced-stage non-small cell lung cancer patients

Published:2016-01 Issue:2 Volume:370 Page:324-331
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Xu Song,Lou Feng,Wu Yi,Sun Da-Qiang,Zhang Jing-Bo,Chen Wei,Ye Hua,Liu Jing-Hao,Wei Sen,Zhao Ming-Yu,Wu Wen-Jun,Su Xue-Xia,Shi Rong,Jones Lindsey,Huang Xue F.,Chen Si-Yi,Chen Jun

Funder

National Natural Science Foundation of China

Doctoral Program of Higher Education

Returned Overseas Chinese Scholars of State Education Ministry

Tianjin Science and Technology Support Program

Tianjin Educational Committee Foundation

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib;Eberhard;J. Clin. Oncol,2005

2. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer;Ludovini;J. Thorac. Oncol,2011

3. Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer;Tsao;J. Clin. Oncol,2007

4. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib;Kobayashi;N. Engl. J. Med,2005

5. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling;Engelman;Science,2007

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Validity and Utility of Circulating Tumor DNA (ctDNA) Testing in Advanced Non-small Cell Lung Cancer (aNSCLC): A Systematic Literature Review and Meta-analysis;Molecular Diagnosis & Therapy;2024-08-02

2. Detection of Single Nucleotide Polymorphisms of Circulating Tumor DNA by Strand Displacement Amplification Coupled with Liquid Chromatography;Analytical Chemistry;2024-03-23

3. ACEK Biosensor for the Minute-Scale Quantification of Breast Cancer ctDNA;Sensors;2024-01-15

4. Clinical applications and perspectives of circulating tumor DNA in gastric cancer;Cancer Cell International;2024-01-06

5. Circulating tumor DNA as liquid biopsy in lung cancer: Biological characteristics and clinical integration;Cancer Letters;2023-11